Jianguo Ma

Shijiazhuang, 050000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.

Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.

Journal: Clinical and experimental medicine

Published: January 03, 2026

Ubiquitination mediated cisplatin resistance in bladder cancer.

Ubiquitination mediated cisplatin resistance in bladder cancer.

Journal: Anti-cancer drugs

Published: November 18, 2025

LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.

LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.

Journal: Clinical and experimental medicine

Published: May 21, 2025

Novel ultrasound scoring system to guide cognitive fusion-targeted biopsy: a prospective study.

Novel ultrasound scoring system to guide cognitive fusion-targeted biopsy: a prospective study.

Journal: Abdominal radiology (New York)

Published: December 29, 2024

Patients with multiple mpMRI region of interests: should we omit targeted biopsies of secondary lesions?

Patients with multiple mpMRI region of interests: should we omit targeted biopsies of secondary lesions?

Journal: Abdominal radiology (New York)

Published: November 28, 2024

Visibility of mpMRI region of interest on ultrasound during cognitive fusion targeted biopsy predicts prostate cancer detection: a prospective single-center study.

Visibility of mpMRI region of interest on ultrasound during cognitive fusion targeted biopsy predicts prostate cancer detection: a prospective single-center study.

Journal: Abdominal radiology (New York)

Published: September 23, 2024

Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells.

Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells.

Journal: Journal of cellular and molecular medicine

Published: March 14, 2024

Potential diagnostic value of multiple indicators combined with total prostate-specific antigen in prostate cancer.

Potential diagnostic value of multiple indicators combined with total prostate-specific antigen in prostate cancer.

Journal: The Journal of international medical research

Published: October 17, 2023

The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis.

The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis.

Journal: Neurourology and urodynamics

Published: September 26, 2023

Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.

Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.

Journal: DNA and cell biology

Published: February 18, 2021

LncRNA LINC00461 Promotes Colorectal Cancer Progression via miRNA-323b-3p/NFIB Axis.

LncRNA LINC00461 Promotes Colorectal Cancer Progression via miRNA-323b-3p/NFIB Axis.

Journal: OncoTargets and therapy

Published: August 27, 2019

Protective effects of scoparone against ischemia‑reperfusion‑induced myocardial injury.

Protective effects of scoparone against ischemia‑reperfusion‑induced myocardial injury.

Journal: Molecular medicine reports

Published: January 09, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026